Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1986-06-17
1987-11-24
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 424 85, 436548, 435 68, 43524027, 4351722, 530387, 530389, 530808, 530809, 935103, 935104, 935107, 935108, 935110, A61K 4300, A61K 3900, C12N 500, G01N 33577
Patent
active
047088621
ABSTRACT:
The present invention relates to the radioimmuno detection of cancers by detecting tumor associated antigens and comprising the following steps:
REFERENCES:
patent: 4349528 (1982-09-01), Koprowski et al.
patent: 4444744 (1984-04-01), Goldenberg
patent: 4471057 (1984-09-01), Koprowski et al.
patent: 4472371 (1984-09-01), Burchiel et al.
Herlyn et al., Proc. Natl. Acad. Sci., U.S.A., 76 (1979) 1438-42.
Koprowski et al., Proc. Natl. Acad. Sci. U.S.A., 75 (1928) 3405-9.
Farrands et al., The Cancer, Aug. 21, 1982, pp. 397-400.
Herlyn et al., Cancer Research 40 (1980) 717-21.
Embleton et al., Chemical Abstracts, 98 (1983) #172695v.
Embleton et al., Chemical Abstracts, 95 (1981) #95310z.
Nucker Christine M.
Xoma Corporation
LandOfFree
Radioimmuno detection of human cancers using anti-tumor monoclon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmuno detection of human cancers using anti-tumor monoclon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmuno detection of human cancers using anti-tumor monoclon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2423434